1 Min Read
Feb 7 (Reuters) - Teva Pharmaceutical Industries Chief Financial Officer Eyal Desheh says:
* Reiterates 2013 revenue forecast $19.5-$20.5 bln, adjusted EPS $4.85-$5.15
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.